Publicaciones en las que colabora con Juan Luis García Hernández (98)

2024

  1. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

2023

  1. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  3. Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake

    Antioxidants, Vol. 12, Núm. 9

2022

  1. Molecular Dissection of Structural Variations Involved in Antithrombin Deficiency

    Journal of Molecular Diagnostics, Vol. 24, Núm. 5, pp. 462-475

  2. Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration

    Cancers, Vol. 14, Núm. 16

2021

  1. Copy neutral loss of heterozygosity (cnLOH) patterns in synchronous colorectal cancer

    European Journal of Human Genetics, Vol. 29, Núm. 4, pp. 709-713

2020

  1. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612

  2. Comment on: Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer

    British Journal of Surgery

  3. Novel dominant kcnq2 exon 7 partial in-frame duplication in a complex epileptic and neurodevelopmental delay syndrome

    International Journal of Molecular Sciences, Vol. 21, Núm. 12, pp. 1-11

2019

  1. Association of polyps with early-onset colorectal cancer and throughout surveillance: novel clinical and molecular implications

    Cancers, Vol. 11, Núm. 12

  2. Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers

    Scientific Reports, Vol. 9, Núm. 1

  3. Clinical and molecular comparative study of colorectal cancer based on age-of-onset and tumor location: Two main criteria for subclassifying colorectal cancer

    International Journal of Molecular Sciences, Vol. 20, Núm. 4

  4. Clinical, cytogenetic, and molecular findings in a patient with ring chromosome 4: Case report and literature review

    BMC Medical Genomics, Vol. 12, Núm. 1

  5. Comparative genomic hybridization analysis of basal cell carcinoma

    JDDG - Journal of the German Society of Dermatology

  6. Intermediate-onset colorectal cancer: A clinical and familial boundary between both early and late-onset colorectal cancer

    PLoS ONE, Vol. 14, Núm. 5

2018

  1. Differential clinicopathological and molecular features within late-onset colorectal cancer according to tumor location

    Oncotarget, Vol. 9, Núm. 20, pp. 15302-15311

2017

  1. A novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1350-1357

  2. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma

    British Journal of Dermatology, Vol. 176, Núm. 5, pp. 1279-1287

  3. Frequency and impact of KRAS mutation in early onset colorectal cancer

    Human Pathology